Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 396947, 9 pages
http://dx.doi.org/10.1155/2014/396947
Research Article

Rho GTPase-Activating Protein 35 rs1052667 Polymorphism and Osteosarcoma Risk and Prognosis

Jinmin Zhao,1,2 Hua Xu,2,3 Maolin He,2,4 Zhe Wang,2,4 and Yang Wu2,4

1Department of Orthopaedics Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
2Research Center for Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
3Center for Education Evaluation & Faculty Development, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
4Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China

Received 5 February 2014; Revised 30 May 2014; Accepted 30 June 2014; Published 20 July 2014

Academic Editor: Urszula Demkow

Copyright © 2014 Jinmin Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jinmin Zhao, Hua Xu, Maolin He, Zhe Wang, and Yang Wu, “Rho GTPase-Activating Protein 35 rs1052667 Polymorphism and Osteosarcoma Risk and Prognosis,” BioMed Research International, vol. 2014, Article ID 396947, 9 pages, 2014. https://doi.org/10.1155/2014/396947.